CKM For Safe Use of SGLT2i in Type 1 Diabetes | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CKM For Safe Use of SGLT2i in Type 1 Diabetes	Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus	Not yet recruiting	Phase 3	2025-10-08		NCT07211802

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abbott	68
Lexicon Pharmaceuticals	6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
National Institutes of Health (NIH)	667
University of California, San Diego	337

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
UCSD - Altman Clinical & Translational Research Institute	La Jolla	United States	1